Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C157 - Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication

Wednesday 04/17/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | 102/104/106
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Matthew Kirschen, MD, PhD, FAAN
Neuro Trauma and Critical Care
Faculty will define scenarios for when continous EEG is indicated in pediatric patients with acute brain injury, discuss risks and benefits of aggressive treatment of subclincal seizures in children with acute brain injuries, describe the pharmacology of ketamine and its role in seizure management, and explore potential risks and benefits from early use of ketamine to treat status epilepticus in critically ill children.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT Introduction Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication
Matthew Kirschen, MD, PhD, FAAN
07:05 AM - 07:15 AM MDT Speaker Epidemiology of Subclinical Seizures After Acute Brain Injury
Giulia Benedetti, MD
07:15 AM - 07:30 AM MDT Speaker Subclinical Seizures: Did We Open Pandora’s Box or Let Out Schrodinger’s Cat?
Craig A. Press, MD, PhD
07:30 AM - 07:45 AM MDT Speaker Subclinical Seizures: Did We Open Pandora’s Box or Let Out Schrodinger’s Cat?
Rodney Craig Scott, MD, PhD
07:45 AM - 08:10 AM MDT Discussion Discussion
Matthew Kirschen, MD, PhD, FAAN
08:10 AM - 08:25 AM MDT Speaker Dissociating Seizures: Ketamine's Role in the Treatment of Status Epilepticus?
Raquel Farias-Moeller, MD
08:25 AM - 08:40 AM MDT Speaker Dissociating Seizures: Ketamine's Role in the Treatment of Status Epilepticus?
Matthew Kirschen, MD, PhD, FAAN
08:40 AM - 09:00 AM MDT Discussion Discussion
Matthew Kirschen, MD, PhD, FAAN
Faculty Disclosures
Matthew Kirschen, MD, PhD, FAAN The institution of Dr. Kirschen has received research support from NIH.
Craig A. Press, MD, PhD Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Giulia Benedetti, MD The institution of Dr. Benedetti has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Benedetti has received research support from NIH.
Raquel Farias-Moeller, MD Dr. Farias-Moeller has nothing to disclose.
Rodney Craig Scott, MD, PhD Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals.